These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36817550)

  • 1. Validation of Sequential ROX-Index Score Beyond 12 Hours in Predicting Treatment Failure and Mortality in COVID-19 Patients Receiving Oxygen via High-Flow Nasal Cannula.
    Basoulis D; Avramopoulos P; Aggelara M; Karamanakos G; Voutsinas PM; Karapanou A; Psichogiou M; Samarkos M; Ntziora F; Sipsas NV
    Can Respir J; 2023; 2023():7474564. PubMed ID: 36817550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of modified ROX index in predicting the outcome of patients with acute respiratory distress syndrome due to SARS-CoV-2 infection treated with high-flow nasal cannula oxygen therapy].
    Wang X; Zhang Z; Cao W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Jun; 36(6):585-590. PubMed ID: 38991956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the successful application of high-flow nasal oxygen cannula in patients with COVID-19 respiratory failure: a retrospective analysis.
    Yu PT; Chen CH; Wang CJ; Kuo KC; Wu JC; Chung HP; Chen YT; Tang YH; Chang WK; Lin CY; Wu CL
    Expert Rev Respir Med; 2023 Apr; 17(4):319-328. PubMed ID: 37002880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of the respiratory rate and oxygenation index for successful high-flow nasal cannula support in coronavirus disease pneumonia: a retrospective cohort study.
    Hirabayashi R; Nagata K; Sato Y; Nakagawa A; Tachikawa R; Kuroda H; Seo R; Morimoto T; Tomii K
    BMC Pulm Med; 2023 Aug; 23(1):294. PubMed ID: 37559018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.
    Kwon H; Ha SW; Kim B; Chae B; Kim SM; Hong SI; Kim JS; Kim YJ; Ryoo SM; Kim WY
    Am J Emerg Med; 2024 Jan; 75():53-58. PubMed ID: 37913715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of high-flow nasal cannula oxygen on patients with chronic obstructive pulmonary disease and mild hypercapnia: a retrospective cohort study based on the Medical Information Mart for Intensive Care-IV database].
    Liu T; Zhao Q; Shi Z; Du B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Jun; 33(6):686-691. PubMed ID: 34296687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
    Chandel A; Patolia S; Brown AW; Collins AC; Sahjwani D; Khangoora V; Cameron PC; Desai M; Kasarabada A; Kilcullen JK; Nathan SD; King CS
    Respir Care; 2021 Jun; 66(6):909-919. PubMed ID: 33328179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study.
    Poopipatpab S; Nuchpramool P; Phairatwet P; Lertwattanachai T; Trongtrakul K
    PLoS One; 2023; 18(6):e0287432. PubMed ID: 37343046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the ROX Index to Predict Treatment Outcome for High-Flow Nasal Cannula and/or Noninvasive Ventilation in Patients With COPD Exacerbations.
    Schaeffer BZ; Fazio SA; Stocking JC; Adams JY; Liu A; Black HB; Harper RW; Cortes-Puch I; Albertson TE; Kuhn BT
    Respir Care; 2024 Aug; 69(9):1100-1107. PubMed ID: 38653556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU.
    Vega ML; Dongilli R; Olaizola G; Colaianni N; Sayat MC; Pisani L; Romagnoli M; Spoladore G; Prediletto I; Montiel G; Nava S
    Pulmonology; 2022; 28(1):13-17. PubMed ID: 34049831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of the use of a high-flow nasal cannula to treat COVID-19 patients and risk factors for failure: a meta-analysis.
    Xu DY; Dai B; Tan W; Zhao HW; Wang W; Kang J
    Ther Adv Respir Dis; 2022; 16():17534666221091931. PubMed ID: 35467449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2.
    Ferrer S; Sancho J; Bocigas I; Bures E; Mora H; Monclou E; Mulet A; Quezada A; Royo P; Signes-Costa J
    Respir Med; 2021; 189():106638. PubMed ID: 34634500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ratio of Oxygen Saturation to Inspired Oxygen, ROX Index, Modified ROX Index to Predict High Flow Cannula Success in COVID-19 Patients: Multicenter Validation Study.
    Ruangsomboon O; Jirathanavichai S; Phanprasert N; Puchongmart C; Boonmee P; Thirawattanasoot N; Dorongthom T; Monsomboon A; Praphruetkit N
    West J Emerg Med; 2023 Apr; 24(3):511-521. PubMed ID: 37278775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROX index and SpO2/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study.
    Kim JH; Baek AR; Lee SI; Kim WY; Na YS; Lee BY; Seong GM; Baek MS
    PLoS One; 2022; 17(5):e0268431. PubMed ID: 35551328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of High-Flow Nasal Cannula Oxygen Therapy in Patients with Mild Hypercapnia.
    Su L; Zhao Q; Liu T; Xu Y; Li W; Zhang A
    Lung; 2021 Oct; 199(5):447-456. PubMed ID: 34448939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive ventilation and high-flow nasal cannula in patients with acute hypoxemic respiratory failure by covid-19: A retrospective study of the feasibility, safety and outcomes.
    Costa WNDS; Miguel JP; Prado FDS; Lula LHSM; Amarante GAJ; Righetti RF; Yamaguti WP
    Respir Physiol Neurobiol; 2022 Apr; 298():103842. PubMed ID: 35026479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure Prediction of High-Flow Nasal Cannula at the Conventional Oxygen Therapy Phase in the Emergency Department.
    Kang Y; Jung HM; Chung SP; Chung HS; Cho Y
    Respiration; 2024; 103(8):488-495. PubMed ID: 38934166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early clinical application and prediction of ROX index in patients with high-flow nasal canula oxygen therapy].
    Liu Y; Xu C; Huang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):823-827. PubMed ID: 37593860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index.
    Roca O; Messika J; Caralt B; García-de-Acilu M; Sztrymf B; Ricard JD; Masclans JR
    J Crit Care; 2016 Oct; 35():200-5. PubMed ID: 27481760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ROX, HROX, and delta-HR indices to predict successful weaning from high-flow oxygen therapy in hospitalized patients with COVID-19 pneumonia.
    Ruchiwit P; Madua J; Saiphoklang N
    PLoS One; 2024; 19(2):e0297624. PubMed ID: 38359052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.